Click Here to Read

WE HAVE TAKEN THE 432 HEADLINES FROM JUNE 2006, JULY 2006, AUGUST 2006 AND PART OF SEPTEMBER FROM OUR MS HOME PAGE AND ARE IN THE PROCESS OF TRANSFERING THEM TO THIS ARCHIVE

PLEASE PARDON OUR CONSTRUCTION....THIS NEW ARCHIVE PAGE WITH IT'S 1,365 HEADLINES WAS JUST COMPLETED 2 DAYS AGO

1,384 HEADLINES ARE BELOW:

Opexa begins trading on NASDAQNEW MS DRUGS:
"Opexa -- formerly called PharmaFrontiers -- has exclusive license from Houston's Baylor College of Medicine for individualized cell therapies and has initiated a Phase IIb clinical trial to evaluate effectiveness in treating MS.

Opexa also holds the exclusive worldwide license from the University of Chicago, through a relationship with Argonne National Laboratory, for patents relating to the use of adult pluripotent stem cells derived from patients' own circulating blood...."

Engineered Immune Cells Beat Back Cancer

Engineered Immune Cells Beat Back Cancer...Scientific American
"....Now scientists have transformed immune cells into cancer fighters outside the body--and prompted complete remission in two subjects when those cells were reintroduced.

Immune cells such as lymphocytes, also known as T cells and pictured in blue above, recognize health threats via special receptors on the cell surface. Steven Rosenberg of the National Cancer Institute and his colleagues first cloned the genes governing the cancer-recognizing receptor in immune cells from a patient who had successfully beaten back melanoma....... "

MS Bike Tour

PERSEVERANCE=A Real Hero: Lauren Zaccaro...working on a NASA project: "...Young, attractive, fit and a successful engineer, Lauren Zaccaro hardly fits the typical description of a woman living with chronic illness. The five-foot, seven-inch blonde looks more like a competitive athlete.... 'Although initially I was somewhat shocked at the diagnosis, I'm thankful that I'm not facing something even worse,' said Zaccaro, who is currently working on a NASA project to remove water and carbon dioxide from the air while maintaining proper cabin pressure and temperature for astronauts in space on a future space vehicle. 'I feel fortunate. The effects of multiple sclerosis aren't keeping me from pursuing my dreams or keeping me from enjoying my favorite activities......'"

’A Million Reasons’ to fight for the disabled:

PERSEVERANCE=Real Heros:
Author Alan Labonte is celebrating the release of his new book, "A Million Reasons." Labonte was diagnosed with MS in 1991 and subsequently fired from his job [CLICK FOR MORE]:
NEW BOOK...."Alan Labonte lives a good life. He has a nice home on Border Street, a loving wife, Lora, and a good job as a member of the faculty at Boston University. But there was a time not too long ago when Labonte found it a struggle to keep a positive outlook on life. After relocating his family to Cohasset from the western part of the state to take on a new job at the law firm of Hutchins & Wheeler, doctors informed him he had contracted MS. He was fired from his job just six months later.

Today, he is happy to be able to share his story with others, through his newly released book, 'A Million Reasons,' published by Cohasset-based publishers Hot House Press.

Labonte is able to share his story with others for one reason: he turned down a $3 million settlement offered by Hutchins & Wheeler. By accepting, he would have also been agreeing to a non-disclosure clause, which would have prevented him from telling his story. Instead, he chose to take a risk and follow his case through the legal system. 'Im sure they couldnt believe it,' said Labonte about turning down the money....."

MS in Focus Magazine

FREE DOWNLOAD: MS in Focus Magazine [available in English, Spanish]
"Issue 8 - Genetics and hereditary aspects of MS.....This issue of MS in focus features articles from the world's most renowned MS genetic scientists, who provide a complete picture of what we know about MS and genetics and what the future holds in this field. Articles comprehensively outline why genetics is important when researching MS, how knowledge about the genetics of MS is being gathered around the world, what remains to be learned, and what this knowledge means to people with MS and their families"

Today Montel will meet people who share his personal battle with MS

"Montel Williams: Today Montel will meet people who share his personal battle with MS.

"Alecia Harris: Multiple Sclerosis Will Not Defeat Me":

PERSEVERANCE=Real Heros: "Alecia Harris is a fighter and will continue to fight as long as MS is her opponent.
Diagnosed with MS in 2001 at the height of her career, Harris changed career paths and made it her point to spread the word about MS and getting tested early.....

"Patient information on cognitive symptoms in multiple sclerosis - acceptability in relation to disease duration.":

Patient information on cognitive symptoms in MS - acceptability in relation to disease duration
[Abstract: National Library of Medicine]
".....Conclusion - Information on cognitive deficits does not increase fears even in recently diagnosed MS patients. Patients with perceived deficits found the information more relevant than others and also less familiar. Thus, it seems appropriate to offer information about cognitive impairments to MS patients."

"Loss of interhemispheric inhibition in patients with multiple sclerosis is related to corpus callosum atrophy.":

Loss of interhemispheric inhibition in patients with MS is related to corpus callosum atrophy
[Centre for Functional Magnetic Resonance Imaging of the Brain, University of Oxford, The John Radcliffe Hospital, Headington, Oxford, OX3 9DU, UK.]
"....Interhemispheric physiological inhibition thus is impaired in patients with MS, potentially contributing to impairment of motor control. This work suggests one way in which FMRI monitoring of the transcallosal interactions in motor cortex could become a tool for evaluation of therapies that may enhance function in reversibly impaired pathways.

MRI findings in benign multiple sclerosis are variable

MRI findings in benign multiple sclerosis are variable - Dept. of Neurology, Mayo Clinic,
[Abstract: Pub Med]

Innate Immunity in Multiple Sclerosis: Myeloid Dendritic Cells in Secondary Progressive Multiple Sclerosis Are Activated and Drive a Proinflammatory Immune Response:

Innate Immunity in MS: Myeloid Dendritic Cells in Secondary Progressive Multiple Sclerosis Are Activated and Drive a Proinflammatory Immune Response
[Karni et al. 177 (6): 4196 -- The Journal of Immunology]
"......These results demonstrate abnormalities of DCs in MS and may explain the immunologic basis for the different stages and clinical patterns of MS."

Prognostic Factors for Early Severity in a Childhood Multiple Sclerosis Cohort:

Prognostic Factors for Early Severity in a Childhood MS Cohort
[Mikaeloff et al. 118 (3): 1133 -- Pediatrics]
".....CONCLUSIONS. The clinical and MRI prognostic factors for early severity that were identified were used as the basis of a predictive tool, which will be validated in another cohort. This tool should make it possible to identify subgroups at risk of early severe disease and should facilitate therapeutic studies"

Heterogeneity at the HLA-DRB1 locus and risk for MS:


".....These results contribute substantially to our understanding of the DRB1 locus and MS, and underscore the importance of using large sample sizes to detect modest genetic effects, particularly in studies of genotype–phenotype relationships."

10 VITAL SIGNS YOUR DOCTOR MIGHT MISS:

10 VITAL SIGNS YOUR DOCTOR MIGHT MISS ]MS is one of the 10
"SOME MEDICAL CONDITIONS CAN BE MISDIAGNOSED OR COMPLETELY MISSED, SO IT'S VITAL TO KNOW ABOUT MORE UNUSUAL SYMPTOMS...."

CLICK

Atlas of MS Database [click for more]
The Multiple Sclerosis International Federation (MSIF) has launched the Atlas of MS a searchable database of information on the epidemiology of multiple sclerosis – who gets MS – as well as treatment access and resources available to people with MS within a particular country, region, or worldwide. There is no charge to use the Atlas.

Data are organized into six categories: epidemiology, services and support, diagnosis, management, treatment, and quality of life. Users can choose a category and region to search for available information. For example, popular queries are: What is the number of MRI machines in Europe? What is the global availability of travel insurance for people with MS? How many hospital-based interdisciplinary teams are available for people with MS in South America?

The value of the Atlas, states the MSIF, “is in replacing impressions and opinions with facts and figures.” The data in the Atlas of MS was compiled by the MSIF and the World Health Organization through a survey of MS-related associations, including member societies of the MSIF such as the National MS Society (USA). Information will be added as it becomes available, and the whole database will be updated every four years. This is a valuable resource for anyone interested in many aspects of multiple sclerosis.

CLICK:

NEW BOOK: "The young person's guide to MS provides information to 10-15 year olds with a parent with MS
The book was written by Kerry Mutch, an MS specialist nurse in Liverpool, who says: 'It can be very lonely for teenagers who have a parent with MS. One of the aims of the book is to help young people explore their feelings about MS and how it affects them, as well as making them realise that they are not alone in the feelings that they may be experiencing at this challenging time of their lives.' This book has been produced with the help of young people who know what it is like to have a parent with MS and who share their experiences, worries and emotions about living with MS in their family....It is split into two sections....."

CLICK HERE TO READ FULL STORY: "Alzheimer's PredictorTwo complementary brain scans can pick up Alzheimer's before it happens.By Brad KlozaSeptember 19, 2006 | Mind & Brain


"Whether it's misplacing your keys or forgetting a phone number, lots of people wonder when simple lapses in memory might be an early sign of Alzheimer's. Now researchers are working on software that might help predict who's really at risk.

New York University brain researchers Susan De Santi and Lisa Mosconi are part of a team developing software that they say will help tell the difference between a person who's just getting old and one who's on the road to Alzheimer's. The software combines information from two different types of brain scans: MRI and PET.

The software takes advantage of the strengths of these two types of brain scans, and each helps mitigate areas where the other is weak. MRI, for instance, is a very good tool to study the inner makeup of the brain and to pinpoint precise locations. PET is much less precise, but does a good job of showing where the brain is using sugar, the energy source of living cells. Plunges in energy use could signal decline in brain function, and the researchers decided to focus on the hippocampus, a part of the brain known to be affected in Alzheimer's.

"What we are trying to do is to find a measure that would predict decline from normal aging to Alzheimer's disease," says Mosconi. "And it looks like the hippocampus is particularly involved in early Alzheimer's disease..."

CLICK:(Liverpool) Tysabri...New MS drug on licensing fast track [CLICK for Full Article]
A NEW drug to treat multiple sclerosis has been accepted for a fast-track assessment process by the Government's health watchdog "New MS drug on licensing fast track"

CLICK
[MS Weber-postdoctoral fellow at the University of California San Francisco (UCSF)
".... Statins can prevent and even reverse ongoing paralysis in experimental autoimmune encephalomyelitis-the mouse model for multiple sclerosis-and on the basis of these findings, statins are now being tested in patients with multiple sclerosis in clinical trials."

CLICK
"....Here, we review current knowledge of the immunopathogenesis of MS and corresponding animal models of disease, and discuss new immunointerventional treatment strategies based on changing pathogenetic concepts..."

CLICK HERE "....Now scientists have transformed immune cells into cancer fighters outside the body--and prompted complete remission in two subjects when those cells were reintroduced.

Immune cells such as lymphocytes, also known as T cells and pictured in blue above, recognize health threats via special receptors on the cell surface. Steven Rosenberg of the National Cancer Institute and his colleagues first cloned the genes governing the cancer-recognizing receptor in immune cells from a patient who had successfully beaten back melanoma....... "